ArticleOncoimmunology
Suppression of indoleamine-2,3-dioxygenase 1 expression by promoter hypermethylation in ER-positive breast cancer.
Dyah L Dewi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
26 papers cite it
pooled itcites it